Latest Schedule 13G passive stakes

Barclays PLC has updated its Schedule 13G filing to reflect beneficial ownership of 3.36% in QVC Group Inc. common stock.

Barclays PLC has updated its Schedule 13G filing to reflect beneficial ownership of 3.36% in QVC Group Inc. common stock.

Several Bank of New York Mellon entities have filed a Schedule 13G, reporting their beneficial ownership of First Trust Horizon Managed Volatility Domestic ETF shares.

Barclays PLC has disclosed beneficial ownership of 5,106,642 shares, representing 10.2% of QVC Group Inc.'s common stock, as of August 31, 2026.

Barclays PLC has disclosed beneficial ownership of 5,106,642 shares, representing 10.2% of QVC Group Inc.'s common stock, as of August 31, 2026.

ARK Investment Management LLC and Catherine D. Wood have filed an amendment to their Schedule 13G, reporting a combined beneficial ownership of 5.11% in Twist Bioscience Corp.

A Schedule 13G filing reveals that 1832 Asset Management L.P., MD Financial Management Inc., and Scotia Capital Inc. collectively hold a substantial 10.77% stake in Boyd Group Services Inc.

HEG Graphite Limited has reported acquiring a 9.9% stake in GrafTech International Ltd through a corporate restructuring, holding 2,577,106 shares.

HEG Advanced Materials Ltd reports a complete divestment of its shares in GrafTech International Ltd, resulting in zero beneficial ownership.

Janus Henderson Group Ltd. has disclosed beneficial ownership of 10.9% of Eyepoint, Inc.'s common stock, as reported in a Schedule 13G filing.

Janus Henderson Group Ltd. has disclosed beneficial ownership of 10.9% of Eyepoint, Inc.'s common stock, as reported in a Schedule 13G filing.

Janus Henderson Group Ltd. has disclosed beneficial ownership of 1,923,076 shares, representing 13.0% of Vogenx, Inc.'s common stock.

Janus Henderson Group Ltd. has updated its beneficial ownership filing for Teleflex Incorporated, reporting a 10.3% stake.

Janus Henderson Group Ltd. has updated its beneficial ownership filing for Teleflex Incorporated, reporting a 10.3% stake.

Janus Henderson Group Ltd. has disclosed beneficial ownership of 3,526,099 shares, representing 10.3% of Ziff Davis, Inc.'s common stock, through various asset management subsidiaries.

Janus Henderson Group Ltd. has disclosed beneficial ownership of 3,526,099 shares, representing 10.3% of Ziff Davis, Inc.'s common stock, through various asset management subsidiaries.

A Schedule 13G filing reveals that 1832 Asset Management L.P., MD Financial Management Inc., and Scotia Capital Inc. collectively hold a substantial 9.32% stake in Open Text Corp.

HSBC Holdings plc has updated its beneficial ownership filing for ATA Creativity Global, now holding 3.7% of the company's American Depositary Shares.

HSBC Holdings plc has updated its beneficial ownership filing for ATA Creativity Global, now holding 3.7% of the company's American Depositary Shares.

Forte Biosciences, Inc. has filed an amendment to its Schedule 13G, reporting changes in beneficial ownership.

Forte Biosciences, Inc. has filed an amendment to its Schedule 13G, reporting changes in beneficial ownership.

State Street Corporation and SSGA Funds Management, Inc. have reported beneficial ownership of 10.2% and 8% respectively in Centrus Energy Corp. common stock.

State Street Corporation and SSGA Funds Management, Inc. have reported beneficial ownership of 10.2% and 8% respectively in Centrus Energy Corp. common stock.

FMR LLC and Abigail P. Johnson have jointly filed an amended Schedule 13G, disclosing beneficial ownership of 1.4% of Tenax Therapeutics Inc.'s common stock as of August 31, 2026.

FMR LLC and Abigail P. Johnson have reported a combined beneficial ownership of 10.2% in Charles River Laboratories International, Inc. as of August 31, 2026.

FMR LLC and Abigail P. Johnson have filed a Schedule 13G, reporting beneficial ownership of 10.6% of Graphic Packaging Holding Co.'s common stock as of August 31, 2026.

FMR LLC and Abigail P. Johnson have reported beneficial ownership of 12.7% of Onterris Inc.'s common stock as of August 31, 2026.

FMR LLC and Abigail P. Johnson have updated their Schedule 13G filing to reflect beneficial ownership of 11.0% of Viatris Inc.'s common stock as of August 31, 2026.

FMR LLC and Abigail P. Johnson have updated their Schedule 13G filing, reporting a combined beneficial ownership of 5.7% in Lenz Therapeutics Inc. as of August 31, 2026.

FMR LLC, along with Abigail P. Johnson, has reported a beneficial ownership of 10.4% in Covista Inc.'s common stock as of August 31, 2026.